Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 12.21B 1.83B 1.66B 1.54B 1.39B 2.62B 171B 2.72B 18.51B 7.32B 92.35B 6.87B 6.73B 292B P/E 2026 *
20.2x
P/E 2027 * 17.3x
Enterprise Value 12.21B 1.83B 1.66B 1.54B 1.39B 2.62B 171B 2.72B 18.51B 7.32B 92.35B 6.87B 6.73B 292B EV / Sales 2026 *
0.74x
EV / Sales 2027 * 0.72x
Free-Float
48.71%
Yield 2026 *
-
Yield 2027 * -
1 day-3.19%
1 week-15.94%
Current month-12.61%
1 month-23.26%
3 months-46.17%
6 months+33.24%
Current year+40.58%
1 week 4.79
Extreme 4.79000000
5.88
1 month 4.79
Extreme 4.79000000
6.21
Current year 2.84
Extreme 2.84
9.86
1 year 2.84
Extreme 2.84
9.86
3 years 2.41
Extreme 2.41
9.86
5 years 2.41
Extreme 2.41
9.86
10 years 2.38
Extreme 2.38
9.86
Manager TitleAgeSince
Chief Executive Officer 64 27/12/2023
Director of Finance/CFO 54 24/12/2004
Investor Relations Contact 45 27/04/2022
Director TitleAgeSince
Director/Board Member 60 08/01/2021
Chairman 56 27/12/2023
Director/Board Member 46 27/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Sell 36,000 0.0014%
01/07/24 Sell 27,000 0.0011%
01/07/24 Sell

Chief Financial Officer

90,000 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%-15.94%+26.63%+33.98% 1.89B
-1.13%-1.17%+38.55%+139.23% 1,275B
-1.36%-0.74%+39.64%+86.06% 680B
-0.59%-0.36%+25.14%+111.73% 521B
-0.76%+1.10%+41.43%+70.96% 389B
-0.75%-3.16%+54.39%+40.90% 356B
-1.83%-0.89%+26.00%+58.48% 305B
-1.65%-0.59%+1.55%+34.52% 287B
-0.95%-1.57%+34.01%+72.55% 250B
+1.60%-0.36%+37.21%+125.66% 208B
Average -1.06%-1.88%+32.45%+77.41% 427B
Weighted average by Cap. -0.98%-0.55%+34.95%+95.59%

Financials

2026 *2027 *
Net sales 16.4B 2.46B 2.23B 2.06B 1.86B 3.51B 230B 3.65B 24.86B 9.83B 124B 9.23B 9.03B 392B 16.94B 2.54B 2.31B 2.13B 1.92B 3.63B 237B 3.77B 25.67B 10.15B 128B 9.53B 9.33B 405B
Net income 607M 90.98M 82.59M 76.3M 68.83M 130M 8.5B 135M 919M 364M 4.59B 341M 334M 14.49B 699M 105M 95.15M 87.89M 79.29M 150M 9.79B 155M 1.06B 419M 5.28B 393M 385M 16.7B
Net Debt - -
Projected Income Statement - Annual - Harbin Pharmaceutical Group Co., Ltd.
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
17/11/26 CN¥4.850 -3.19% 157,296,790
16/11/26 CN¥5.010 -3.09% 181,469,721
13/11/26 CN¥5.170 -8.98% 330,212,367
12/11/26 CN¥5.680 -1.05% 272,031,110
11/11/26 CN¥5.740 -0.52% 204,183,991
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.850CNY
Average target price
9.160CNY
Spread / Average Target
+88.87%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Harbin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 600664 Stock